已收盘 02-06 16:00:00 美东时间
+1.240
+10.74%
Lifco Ab ( ($SE:LIFCO.B) ) has shared an update. Lifco AB has agreed to acquire...
01-30 16:28
K2 Capital Acquisition Corp.涨0.30%,最新市值1.46亿美元;Picpay Holdings Netherlands B.V.涨0.00%,最新市值24.62亿美元;York Space Systems (Yellowstone)跌1.15%,最新市值42.01亿美元;aTyr制药跌11.32%,最新市值10.61亿美元;
01-30 06:00
UPDATE 2-York Space valued at $4.75 billion as shares surge in NYSE debut Updates throughout Jan 29 (Reuters) - York Space Systems YSS.N clinched a valuation of $4.75 billion in its market debut, as investors bet on sustained Pentagon spending on space and defense to drive growth . The Denver, Color
01-30 01:28
Insurance platform Ethos Technologies opens flat in Nasdaq debut Jan 29 (Reuters) - Ethos Technologies' LIFE.O shares opened flat in their Nasdaq debut on Thursday, giving the insurance technology company a valuation of $1.2 billion. (Reporting by Manya Saini and and Arasu Kannagi Basil in Bengaluru
01-30 01:16
BRIEF-Ethos Says IPO Of 10.5 Million Shares At Price Of $19.00 Per Share Jan 28 (Reuters) - ETHOS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING ETHOS- INITIAL PUBLIC OFFERING PRICE OF $19.00 PER SHARE ETHOS- PRICING OF INITIAL PUBLIC OFFERING OF 10.5 MILLION SHARES OF CLASS A COMMON STOCK AT AN INITI
01-29 11:38
Ethos Technologies prices IPO at $19 per share, Bloomberg News reports Jan 28 (Reuters) - Insurance platform Ethos Technologies priced its U.S. initial public offering at $19 per share, Bloomberg News reported on Wednesday, citing a person familiar with the matter. Reuters could not immediately veri
01-29 09:40
What to Watch in the Day Ahead - Thursday, January 29 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Workspace/Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All
01-29 03:32
ATyr Pharma's stock dips after Phase 3 trial of efzofitimod misses steroid reduction goal, but shows improvements in lung function and steroid withdrawal rates.
2025-09-15 23:24
ATyr Pharma Announces Topline Results From Phase 3 Efzo-Fit™ Study of Efzofitim...
2025-09-15 19:31
ATyr Pharma Inc - Study Did Not Meet Primary Endpoint in Ocs Dose Change
2025-09-15 19:31